Latest Research in Renal cell carcinoma treatment
189 research papers · 2026 median publication year
Top Research Topics in Renal cell carcinoma treatment
- Renal cell carcinoma treatment — 19 papers
- Cancer Genomics and Diagnostics — 19 papers
- Genetic factors in colorectal cancer — 15 papers
- Cancer Immunotherapy and Biomarkers — 12 papers
- Autoimmune and Inflammatory Disorders Research — 10 papers
- BRCA gene mutations in cancer — 7 papers
- Ovarian cancer diagnosis and treatment — 6 papers
- Inflammatory Biomarkers in Disease Prognosis — 4 papers
- Lymphadenopathy Diagnosis and Analysis — 3 papers
- Esophageal Cancer Research and Treatment — 3 papers
Highest-Cited Papers
- CRIF1 promotes aggressive phenotypes and is associated with reduced paclitaxel-induced apoptosis in endometrial cancer cells through Wnt/β-catenin-related signaling
- Efficacy and safety of Romiplostim N01 for grades II to IV cancer therapy induced thrombocytopenia in a real world observational study
- A reproducibility benchmark of transcriptomic prognostic signatures in clear-cell renal cell carcinoma: protocol, feasibility assessment, and a survival-availability obstacle
- A reproducibility benchmark of transcriptomic prognostic signatures in clear-cell renal cell carcinoma: protocol, feasibility assessment, and a survival-availability obstacle
- Tumor mutational burden as a prognostic biomarker for survival and quality of life in metastatic colorectal cancer patients receiving anti-PD-1/PD-L1 immunotherapy
- Plasma signals of lung tumor promotion and the ubiquitous challenge of biomarker specificity
- Arsenic-endemic regions correlate with elevated tumor mutational burden and genomic alterations in urothelial carcinoma
- Isolated MSH2 Loss With Divergent Microsatellite Instability Status in Colorectal and Prostate Adenocarcinoma: A Diagnostic Pitfall
- A non-invasive diagnostic model for early detection of gastric and colorectal cancers using serum glycopeptide profiling and machine learning
- Biomarkers in Clear Cell Renal Cell Carcinoma: From Biological Association to Clinical Decision-Making
- An update on APC I1307K homozygosity: observations from a large multigene panel testing cohort
- Bibliometric mapping and trend analysis of RNA interference-related patient-derived organoid research in colorectal cancer
- The Pathogenesis of Epithelial Ovarian Cancer
- Enteric-type urachal adenocarcinoma harboring an EIF3E::RSPO2 fusion with durable response to immune checkpoint inhibition: a case report
- Endocrine adverse events related to immune checkpoint inhibitors in gastric cancer
- Influence of Variant of Uncertain Significance (VUS) Genetic Testing Results on Mastectomy Choice in Lumpectomy-Eligible Patients
- 0077Aromatase Inhibitors Versus Tamoxifen and Cardiovascular-Kidney-Metabolic Stage Progression in Women with Breast Cancer: A Real-World Database Propensity-Matched Cohort Study
- Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: “Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications”
- TROP2 expression in gastric and GEJ adenocarcinomas: associations with clinicopathological features, biomarkers, and treatment outcomes
- Kikuchi–Fujimoto disease presenting as cervical lymphadenopathy mimicking tuberculous lymphadenitis in a young woman with vitiligo: a case report